APOH and autoimmune polyendocrinopathy: SN-CAPS differs from CAPS in that patients do not demonstrate conventional serological markers of APS: anti-beta-2-glycoprotein 1, LA, or aCL by enzyme-linked immunoassay (ELISA) [8].